H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 171 Citations 134,300 1,127 World Ranking 180 National Ranking 2

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Disease

His primary scientific interests are in Internal medicine, Endocrinology, Cholesterol, Odds ratio and Prospective cohort study. His Internal medicine research is multidisciplinary, relying on both Population study and Cardiology. His Endocrinology research includes themes of Mendelian randomization and Risk factor.

His Cholesterol study deals with C-reactive protein intersecting with Rosuvastatin Calcium and Rosuvastatin. His Odds ratio study also includes

  • Genome-wide association study, Single-nucleotide polymorphism and Prostate cancer most often made with reference to Oncology,
  • Breast cancer and related Case-control study and TOX3. Børge G. Nordestgaard interconnects Arteriosclerosis, Proportional hazards model, Cohort study and Mendelian Randomization Analysis in the investigation of issues within Prospective cohort study.

His most cited work include:

  • Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. (4538 citations)
  • Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein (3523 citations)
  • Genome-wide association study identifies novel breast cancer susceptibility loci (2045 citations)

What are the main themes of his work throughout his whole career to date?

Internal medicine, Endocrinology, Population study, Hazard ratio and Odds ratio are his primary areas of study. His Internal medicine research integrates issues from Oncology and Cardiology. His Endocrinology study frequently links to related topics such as Risk factor.

Børge G. Nordestgaard combines subjects such as Gastroenterology, COPD, Cohort study and Body mass index with his study of Population study. His Hazard ratio study combines topics from a wide range of disciplines, such as Proportional hazards model, Prospective cohort study and Surgery. As a part of the same scientific family, Børge G. Nordestgaard mostly works in the field of Odds ratio, focusing on Mendelian randomization and, on occasion, Mendelian Randomization Analysis and Confounding.

He most often published in these fields:

  • Internal medicine (104.91%)
  • Endocrinology (31.67%)
  • Population study (37.44%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (104.91%)
  • Population study (37.44%)
  • Hazard ratio (30.25%)

In recent papers he was focusing on the following fields of study:

Børge G. Nordestgaard mainly investigates Internal medicine, Population study, Hazard ratio, Cholesterol and Myocardial infarction. Børge G. Nordestgaard has researched Internal medicine in several fields, including Endocrinology, Oncology and Cardiology. His work in the fields of Endocrinology, such as Very low-density lipoprotein and Diabetes mellitus, intersects with other areas such as Context.

The concepts of his Population study study are interwoven with issues in Body mass index, Cohort study, Gastroenterology, Confidence interval and Disease. His Hazard ratio research focuses on Prospective cohort study and how it relates to Epidemiology. The study incorporates disciplines such as Stroke, Statin, Interquartile range and Number needed to treat in addition to Myocardial infarction.

Between 2018 and 2021, his most popular works were:

  • Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (257 citations)
  • Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (257 citations)
  • Lipoprotein(a) Reduction in Persons with Cardiovascular Disease. (142 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Cancer

Børge G. Nordestgaard mainly focuses on Internal medicine, Population study, Myocardial infarction, Lipoprotein and Cholesterol. His Internal medicine research incorporates elements of Gastroenterology and Oncology. Børge G. Nordestgaard interconnects Blood pressure, FEV1/FVC ratio, Number needed to treat, Systemic inflammation and Confounding in the investigation of issues within Population study.

His Myocardial infarction research includes themes of Stroke, Lower risk, Confidence interval and Biomarker. His study in Lipoprotein is interdisciplinary in nature, drawing from both Risk factor and Apolipoprotein B. His Cholesterol study contributes to a more complete understanding of Endocrinology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Paul M Ridker;Eleanor Danielson;Jacques Genest;Antonio M. Gotto.
The New England Journal of Medicine (2008)

7489 Citations

Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

Paul M. Ridker;Eleanor Danielson;Francisco A. H. Fonseca;Jacques Genest.
Obstetrical & Gynecological Survey (2009)

6000 Citations

Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women

Børge G. Nordestgaard;Marianne Benn;Peter Schnohr;Anne Tybjærg-Hansen.
JAMA (2007)

2629 Citations

Genome-wide association study identifies novel breast cancer susceptibility loci

Douglas F. Easton;Karen A. Pooley;Alison M. Dunning;Paul D. P. Pharoah.
Nature (2007)

2560 Citations

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

Borge G. Nordestgaard;M. John Chapman;Steve E. Humphries;Henry N. Ginsberg.
European Heart Journal (2013)

2341 Citations

Lipoprotein(a) as a cardiovascular risk factor: current status

Børge G. Nordestgaard;M. John Chapman;Kausik Ray;Jan Borén.
European Heart Journal (2010)

1611 Citations

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

Brian A Ference;Henry N Ginsberg;Ian T. Graham;Kausik K Ray.
European Heart Journal (2017)

1461 Citations

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

M John Chapman;Henry N Ginsberg;Pierre Amarenco;Felicita Andreotti.
European Heart Journal (2011)

1287 Citations

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.

Paul M Ridker;Eleanor Danielson;Francisco Ah Fonseca;Jacques Genest.
The Lancet (2009)

1231 Citations

Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.

Pia R. Kamstrup;Anne Tybjærg-Hansen;Rolf Steffensen;Børge G. Nordestgaard.
JAMA (2009)

1144 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Børge G. Nordestgaard

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 384

Gerald F. Watts

Gerald F. Watts

University of Western Australia

Publications: 329

Paul M. Ridker

Paul M. Ridker

Harvard Medical School

Publications: 274

Douglas F. Easton

Douglas F. Easton

University of Cambridge

Publications: 250

Roger L. Milne

Roger L. Milne

Cancer Council Victoria

Publications: 245

George Davey Smith

George Davey Smith

University of Bristol

Publications: 244

Paul D.P. Pharoah

Paul D.P. Pharoah

University of Cambridge

Publications: 228

Melissa C. Southey

Melissa C. Southey

Cancer Council Victoria

Publications: 221

Jenny Chang-Claude

Jenny Chang-Claude

German Cancer Research Center

Publications: 217

Maciej Banach

Maciej Banach

Medical University of Lodz

Publications: 206

John L. Hopper

John L. Hopper

University of Melbourne

Publications: 194

Peter Kraft

Peter Kraft

Harvard University

Publications: 185

Christopher A. Haiman

Christopher A. Haiman

University of Southern California

Publications: 181

Winfried März

Winfried März

Heidelberg University

Publications: 173

Sekar Kathiresan

Sekar Kathiresan

Harvard University

Publications: 172

Something went wrong. Please try again later.